当前位置: 首页 > 期刊 > 《第四军医大学学报》 > 2004年第19期
编号:10872720
蛋白酶激活受体2激动剂诱导上皮细胞分泌MCP1
http://www.100md.com 《第四军医大学学报》 2004年第19期
蛋白酶激活受体,,蛋白酶激活受体;上皮细胞系;单核细胞趋化蛋白1,0引言,1材料和方法,2结果,3讨论,【参考文献】
     Induction of secretion of MCP1 from epithelial cells by proteinase activated receptors2 agonists

    WANG HaiYan, HE ShaoHeng

    Allergy and Inflammation Research Institute, Shantou University Medical College, Shantou 515031, China

    【Abstract】 AIM: To investigate the actions of agonists of proteinase activated receptors (PAR)2 on the secretion of monocyte chemoattractant protein1 (MCP1) from human lung epithelial cells. METHODS: A549 cells were cultured in a 12well culture plate. The challenge was performed by adding various concentrations of PAR2 agonists or their reverse peptides into each well, respectively. After 2 h, 8 h or 16 h, the reactions were terminated by removal of the supernatant from each well. A Sandwich ELISA was used to determine the levels of MCP1 in supernatants. RESULTS: Following 16 h incubation, PAR2 agonists SerLeuIleGlyLysValamide (SLIGKV) and transcinnamoylLeuIleGlyArgLeuOrnamide (tcLIGRLO) were able to induce concentration dependent secretion of MCP1. The maximum release of MCP1 was 13 fold more than the baseline release. The reverse PAR2 agonists had little effects on MCP1 release. The time course showed that the actions of PAR2 agonists initiated at 2 h and reached their peaks at 16 h. CONCLUSION: Agonists of PAR2 are potent secretogogues of MCP1 release from cultured human lung epithelial cells. Their antagonists may possess the ability to inhibit airway inflammation. ......

您现在查看是摘要页,全文长 7566 字符